# Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

> **NCT02018458** · PHASE1,PHASE2 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** LA TNBC: DC vaccine+Preop chemo
- **BIOLOGICAL:** ER+/HER2-BC:DC vaccine+Preop chemo

## Key facts

- **NCT ID:** NCT02018458
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-09-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018458, "Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02018458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*